Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 23;10(1):e0115836.
doi: 10.1371/journal.pone.0115836. eCollection 2015.

A large-scale seroprevalence of Epstein-Barr virus in Taiwan

Affiliations

A large-scale seroprevalence of Epstein-Barr virus in Taiwan

Chao-Yu Chen et al. PLoS One. .

Abstract

Background: Epstein-Barr virus (EBV) causes a variety of clinical manifestations from asymptomatic infection to acute infectious mononucleosis in human. Moreover, the EBV infection is associated with malignancies. The large-scale EBV seroepidemiology across all age groups has been lacking in Taiwan.

Methods: A total of 1411 serum samples were tested to examine the seroprevalence of EBV in 2007. The samples were collected during an island-wide seroepidemiological survey of vaccine preventable diseases in Taiwan. The enzyme-linked immunosorbent assay was performed to detect anti-EBV viral capsid IgG in sera. Demographic and personal health data were obtained by questionnaires.

Results: The overall weighted seropositive rate of EBV was 88.5% (95% CI, 86.7%-90.1%). The seropositive rate of EBV reached 52.8% (95% CI, 44.0%-61.6%) in children aged 2 years, rapidly rose to 88.7% (95% CI, 79.0%-95.1%) in those aged 5-7 years and 93.0% (95%CI, 83.0%-98.1%) for those aged 14-16 years. Age and higher educational level were associated with the increased EBV seropositive rate.

Conclusion: In Taiwan, people had the EBV infection early in life. Children under 7 years should be the primary target popution of public health measures in the future.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343: 481–492. 10.1056/NEJM200008173430707 - DOI - PubMed
    1. Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, et al. (2013) Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 207: 80–88. 10.1093/infdis/jis646 - DOI - PMC - PubMed
    1. Tsai MH, Hsu CY, Yen MH, Yan DC, Chiu CH, et al. (2005) Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children. J Microbiol Immunol Infect 38: 255–261. - PubMed
    1. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, et al. (2001) Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98: 280–286. 10.1182/blood.V98.2.280 - DOI - PubMed
    1. Chen CJ, Huang YC, Jaing TH, Hung IJ, Yang CP, et al. (2004) Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect 37: 157–163. - PubMed

Publication types

LinkOut - more resources